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Summary
Choriocarcinoma is one of the histological types of entities called gestational trophoblastic neoplasia (GTN) that refers 
to a rare group of malignancies that are formed by abnormal proliferation of trophoblastic tissue. Choriocarcinoma is the 
most aggressive GTN histological type and is characterized by early vascular invasion and disseminated disease. The clini-
cal presentation depends on the spread of the disease and the location of the seedlings. In this paper we present the case of 
a 32-year-old patient sent to our Department for a specific oncological treatment of uterine choriocarcinoma diagnosed in an 
external institution. The disease is according to FIGO and WHO scale classified as III stage, low risk and chemotherapy with 
methotrexate and folic acid is indicated.  The chemotherapy achieved negativity of the initially elevated tumor marker hu-
man chorionic gonadotropin (hCG) and full regression of lesions described in computerized tomography (CT).
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INTRODUCTION
Choriocarcinoma is one of the histological 
types of entities called gestational trophoblastic 
neoplasia (GTN), that refers to a rare group of ma-
lignancies that are formed by abnormal prolifera-
tion of trophoblastic tissue, which can be preceded 
by either a hydatidiform mole or nonmolar preg-
nancy. GTN besides choriocarcinoma also involes 
histological types: invasive mole (IM),  placental 
site trophoblastic tumor (PSTT), and epithelioid 
trophoblastic tumor (ETT). IM and choriocarcino-
ma are characterized by high values  of human 
chorionic gonadotropin (hCG) while PSTT and 
ETT are characterized by low hCG values (1). At a 
time prior to the development of effective chemo-
therapy for GTN, most patients with disease lim-
ited to uterus were cured with hysterectomy while 
the metastatic  disease was mostly fatal (2). Nowa-
days, in the development of high sensitivity as-
says for hCG determination and treatment with 
high-efficiency chemotherapy,  most patients can 
be cured as well as preserve reproductive function 
(3). Almost 50% of GTN is derived from molar 
pregnancy, 25% from spontaneous abortion or ec-
topic (tubular) pregnancy and 25% from terminal 
or premature pregnancy. The ultimate cause of 
gestational throphoblastic disease is claimed to be 
genetic in origin. No enviromental etiological fac-
tor has been implicated up to now apart from de-
ficient vitamin A precursor carotene in the diet (4). 
Choriocarcinoma is the most aggressive GTN his-
tological type and is characterized by early vascu-
lar invasion and disseminated disease. The clinical 
presentation depends on the spread of the disease 
and the location of the seedlings.
PATIENT REPORT
In May 2018 a 32-year-old patient was re-
ferred to the Department of Gynecological Oncol-
ogy, University Hospital Centre Zagreb for a spe-
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cific oncological treatment of a pathohistologically 
verified uterine choriocarcinoma. Previously in 
the other institution uterine vacuum aspiration 
was done due to the suspected molar hydatidose 
in 7th week of amenorrhea.
The pathohistological findings were: accord-
ing to histologic and immunohistochemical analy-
sis (Ki-67 in atypical trophoblast cells, primarily 
cytotrophoblasts, about 90%, CK 8/18 intensively 
positive, alpha-inhibitory only focal positive, p63 
negative) findings in this material correspond to 
neoplasms of trophoblast, choriocarcinoma.
Gynecological ultrasound finding: in uterine 
cavity conglomerate about 3 cm, CD  highly vas-
cularization. Normal ovaries. No ascites. The hCG 
value before uterine vacum aspiration was 45,627 
and after aspiration 19,246. In our Department 
further diagnostic processing was done:
Brain CT: no signs of acute ischemia, intra-
cranial hemorrhage and expansive lesions of the 
brain parenchyma. Chest, abdominal and pelvic 
CT: three small hypodensis lesions of 0.4 cm in di-
ameter, insufficient size for characterization, can 
fit very small cysts in the right liver lobe. Appro-
priate morphology of the spleen, kidneys, adrenal 
glands and pancreas. The uterus is in retroversio-
flexio (RVF), an extended cavity, filled with dense 
contents and irregular hypovascular endometri-
um. In the area of both ovaries that are not en-
larged, there are small oval cystic lesions, proba-
bly corresponding to functional cysts. There are 
no free intraperitoneal fluids. In the hepatogastric 
ligament there are reproduced lymph nodes, the 
largest dimension being 1.7 x 0.9 cm. There are no 
enlarged lymph nodes in the retroperitoneum of 
lumbar regions, pelvis and inguinal organs. There 
are no enlarged lymph nodes at the base of the 
neck, axillary and mediastinum. Peripheral and 
subpleurally located nodules are located in both 
lungs, the largest subpleural ventral mid lobe of 
the right lung  0.9 cm in diameter, lateral in the 
lower lobe of the left lung 0.6 cm in diameter, and 
the lower lobe of the right lung in diameter of 0.7 
cm , which are surrounded by dairy-type areas, 
may correspond to secondary focal lesions. No 
pleural effusion.
The disease is according to FIGO and WHO 
scale classified as III stage, low risk and chemo-
therapy with methotrexate and folinic acid (MTX/
FA) is indicated. In the period from June to Sep-
tember 2018. patient received 8 cycles of MTX / FA 
chemotherapy: methotrexate 50 mg im. Day (D)1, 
D3, D5, D7 and folinic acid 15 mg po. D2, D4, D6, 
D8. There were no delays, difficultes or side ef-
fects during chemotherapy. hCG values during 
therapy: Before 1.cycle (c) of chemotherapy: 36, 
013;  before 2.c.: 2,717.94; before 3.c.: 183.39; before 
4.c.:30.13;  before 5.c.: 9.76; before 6.c.: negative; 
before 7. c.: negative; before 8.c.: negative.
Control diagnostic after chemotherapy: 
Chest, abdominal and pelvic CT (October 2018.): 
in the control interval in both lungs there is almost 
complete regression of the number and size of the 
previously described bilateral secondary nodules, 
at the site of the largest nodules are now only seen 
punktiform residual nodules. The rest is neat.
And at the end hCG: negative. We recom-
mended patient contraception for at least one year 
and a regular, monthly hCG control. Since chemo-
therapy is completed 6 months ago, all the current 
values of hCG are normal, negative, and the con-
trol chest, abdominal and pelvic CT done in Janu-
ary 2019. was neat.
DISCUSSION
Gestational  throphoblastic neoplasia almost 
always develops with or follows some form of rec-
ognized pregnancy. Most follow a hydatidiform 
mole but it may follow term or preterm pregnan-
cy, miscarriage or tubal pregnancy (5,6). Chorio-
carcinoma is the most aggressive GTN histologi-
cal type and is characterized by early vascular in-
vasion and disseminated disease. The clinical 
presentation depends on the spread of the disease 
and the location of the seedlings. Most common 
sites of metastasis are lungs. Patients diagnosed 
with choriocarcinoma should undergo evaluation 
prior to treatment to assess stage and ability to tol-
erate chemotherapy. The disease is staged by 
FIGO and WHO scoring system and the treatment 
is based on the total score which signifies the risk 
of the patient developing single-agent drug resis-
tance. Patient with non-metastatic disease (Stage 
I) and low-risk metastatic (Stages II and III, score < 
7) can be treated initially with single-agent che-
motherapy, preferably methotrexate with cure 
rates approaching 80-90% (7). Women with a low-
risk disease have a good prognosis, even if tumor 
has spread, because treatment is usually very ef-
fective. Choriocarcinoma is characterized by high 




Uterine choriocarcinoma is rare malignancy 
and is the most aggressive GTN histological type 
characterized by early vascular invasion and dis-
seminated disease but it is also highly chemosen-
sitive with high cure rates in early stage. It is im-
portant to do adequate radiological exam and to 
properly stage the disease prior to chemotherapy 
treatmen.
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Sažetak
KORIOKARCINOM MATERNICE – PRIKAZ SLUČAJA
V. Paradžik Pašalić, J. Lešin, V. Matković i S. Lide Škalec
Koriokarcinom jedan je od histoloških tipova gestacijske trofoblastične neoplazije (GTN), rijetke skupine malignoma 
nastale abnormalnom proliferacijom tkiva trofoblasta i predstavlja najagresivniji histološki tip GTN. Odlikuje se ranim 
 krvožilnim bujanjem i udaljenim presadnicama. Klinička slika ovisi o proširenosti bolesti i smještaju presadnica. U ovom 
radu prikazan je slučaj 32 godišnje bolesnice upućene u našu ustanovu radi specifičnog liječenja koriokarcinoma maternice 
dijagnosticiranog u drugoj ustanovi. Bolest je prema FIGO i WHO ljestvici klasificirana u III stadij niskog rizika. Liječenje 
metotreksatom i folnom kiselinom dovelo je do negativizacije početno izrazito povišenog tumorskog biljega humanog 
 korionskog gonadotropina (hCG) i potpunog povlačenja promjena opisanih CT-om.
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